Connect with us
  • Elysium

Multiple sclerosis news

Five warning signs for MS five years before diagnosis



People who develop Multiple Sclerosis (MS) are more likely to have a number of underlying conditions years before their diagnosis, a new study reveals. 

Research has shown it is more likely that people who go on to have MS will have conditions like depression, constipation and urinary tract infections five years before their diagnosis. 

The study also found that sexual problems and bladder infections are also a greater possibility. 

“Knowing that these conditions may be prodromal symptoms or even early-stage symptoms of MS would not necessarily lead to earlier diagnosis of the disease in the general population, since these conditions are common and could also be signs of other diseases, but this information could be helpful for people who are at a higher risk of developing MS, such as people with a family history of the disease or those who show signs of MS on brain scans but do not have any symptoms of the disease,” said study author Dr Celine Louapre, of Sorbonne University in Paris, France.

The study involved 20,174 people newly diagnosed with MS. They were each matched with three people who did not have MS of the same age and sex, for a total of 54,790 people. 

Those with MS were also compared to 30,477 people with Crohn’s disease and 7,337 people with lupus, both of which are other autoimmune diseases. 

Then researchers used the medical records database to see whether the participants had any of 113 diseases and symptoms in the five years before and after their diagnosis, or before that matching date for the people who did not have an autoimmune disease.

The people with MS were 22 per cent more likely to have depression five years before their diagnosis than the people without MS. They were 50 per cent more likely to have constipation, 38 per cent more likely to have urinary tract infections, 47 per cent more likely to have sexual problems, and 21 per cent more likely to have cystitis, or bladder infections.

For depression, 14 per cent of the people with MS had prescriptions for antidepressants five years before diagnosis, compared to 10 per cent of the people who did not have MS. 

By five years after diagnosis, 37 per cent of people with MS had antidepressant prescriptions, compared to 19 per cent of those without MS.

“Of course, not everyone who has these symptoms will go on to develop MS,” Dr Louapre said. 

“We’re hoping that eventually these early signs will help us understand the biological mechanisms that occur in the body before the actual symptoms of the disease develop.”